Top Growth Trends in the Asthma Drugs Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the asthma drugs market?
In the previous years, the market size for asthma medications has significantly expanded. It’s expected to increase from $23.96 billion in 2024 to $25.17 billion in 2025, projecting a compound annual growth rate (CAGR) of 5.0%. The surge witnessed during the historic period can be linked to environmental factors, a surge in respiratory ailments, modifications in lifestyle, and the expansion of healthcare infrastructure.
What will be the asthma drugs market size in the future?
The market for asthma medications is anticipated to experience significant expansion in the coming years. The projected growth is estimated to be $31.98 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. This expected growth in the forecast period is due to factors like increasing levels of air pollution, an expanding elderly population, heightened healthcare awareness, the trend towards personalized medicine, and biopharmaceutical advancements. Some of the major trends to watch during this forecast period include small-molecule treatments, asthma care in home settings, therapies guided by biomarkers, advancements in treating severe asthma, and collaborative efforts for asthma research.
Get your asthma drugs market report here!
https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report
What main drivers are fueling expansion in the asthma drugs market?
The swell in asthmatic conditions is anticipated to bolster the expansion of the asthma drug market in the future. Asthma is a chronic illness that triggers inflammation and swelling, narrowing the airways that transport air from our nose and mouth to our lungs. The rise in asthma incidences has led to the discovery of new asthma medications to manage these conditions. For example, in April 2024, Asthma + Lung UK, an England-based charity addressing lung ailments, reported that in 2021, 1,146 asthma-related mortalities were registered in England. However, this number increased to 1,236 in 2022, demonstrating a worrying growth in deaths linked to asthma during the year.
What key areas define the segmentation of the global asthma drugs market?
The asthma drugs market covered in this report is segmented –
1) By Type Of Asthma: Allergic, Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma
3) By Therapy: Preventive, Curative
4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs
5) By End-User: Asthma Patients, COPD Patients
Subsegments:
1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies
2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp
Who are the dominant players expanding their reach in the asthma drugs market?
Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited
How are evolving market trends shaping asthma drugs Strategies?
Major companies engaged in the business of asthma drugs are directing their focus on ground-breaking innovations like fixed-dose combination (FDC) drugs. These are devised to heighten the effectiveness of treatment and boost patient compliance. An FDC drug is a medication that consolidates two or more active constituents into a single dosage form like a tablet, capsule or inhaler. For instance, Glenmark Pharmaceuticals, a pharmaceutical corporation based in India, introduced Indamet in June 2022, a fixed-dose combination (FDC) drug in India. This is specifically designed for patients struggling with uncontrolled asthma. Indamet is a pioneering treatment that amalgamates Indacaterol, a long-lasting beta-agonist, with Mometasone Furoate, an inhaled corticosteroid. It comes in varied strengths such as Indacaterol 150 mcg combined with Mometasone at 80 mcg, 160 mcg, and 320 mcg. Indamet is designed for once-daily usage and primarily targets adults and adolescents who are 12 years of age and over.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11924
Which regions are emerging as leaders in the asthma drugs market?
North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Delivery Drones Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/delivery-drones-global-market-report
Drugs For Erectile Dysfunction Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
